Books by splitShops

Science Business: The Promise, the Reality, and the Future of Biotech - Hardcover

$35.00

Tax not included.
Shipping calculated at checkout.

In stock

Order Note:

Purchase Information

Shipping charges, applicable taxes, the final order total, and available payment methods are shown during checkout before payment. Delivery timing varies by item and fulfillment origin. Standard U.S. returns are by mail for eligible new, unopened items within 30 days of carrier delivery. Customers pay standard return shipping; there is no restocking fee. Approved refunds are issued within 5 business days after the return is received and inspected. Standard exchanges are not offered.

Cindi Book items have a flat $9.99 shipping charge. Shopify Collective items use shipping rates set by the supplier. Orders containing items from different fulfillment sources may include more than one shipping charge. Your full shipping total is shown at checkout before payment.

Return eligibility is subject to the full policy. Opened, read, or unsealed books with broken seals or visible wear are final sale. Digital downloads, gift cards, and personalized products are non-refundable. Original shipping charges are not refunded for standard returns. Contact us within 7 days of delivery about damaged, defective, or incorrect items.

by Gary P. Pisano (Author)

Why has the biotechnology industry failed to perform up to expectations--despite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter--term 'monetisation' of intellectual property. Pisano maintains that all industry players--biotech firms, investors, universities, pharmaceutical companies, government regulators--can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being.

Author Biography

Gary P. Pisano is the Harry E. Figgle Jr. Professor of Business Administration and Head of the Technology and Operations Management unit at Harvard Business School.

Number of Pages: 256
Dimensions: 1.04 x 9.48 x 6.44 IN
Publication Date: November 01, 2006

Pay with

  • Amazon
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • PayPal
  • Shop Pay
  • Visa

Available payment methods and your final total are shown at checkout before payment.

$35.00